Immunohistochemistry is the method of choice in the differential diagnosis of neoplastic pleurisies of unknown etiology
Abstract
The study included 61 patients with exudative neoplastic pleurisy of unknown primary localization. All patients underwent immunocytochemical study of pleural exudate to determine the etiology of effusion. Immunocytochemistry of 55 patients (90 %) of 61 ones was effective. The reason of exudation was both primary tumors — lung cancer (22), pleural mesothelioma (4) and pleural metastases of tumors of other localization - cancers of ovaries (9), breast (4), kidney (3), uterine body (2) , malignant lymphoma (2), colon (2), pancreas (2), thyroid gland (2), stomach (1), prostate (1), vagina (1). Immunocytochemical study of pleural effusions is the method of choice for the differential diagnosis of neoplastic pleurisies of unknown etiology.
About the Authors
O. V. IvanovRussian Federation
V. N. Klimenko
Russian Federation
V. I. Novik
Russian Federation
G. V. Nikolaev
Russian Federation
References
1. Волобуев А. В. Видеоторакоскопия в диагностике опухолевых заболеваний легких и плевры: автореф. дис. ... канд. мед. наук, 2006.
2. Григорук О. Г., Лазарев А. Ф., Богатырев В. Н. Дифференциальная цитологическая диагностика плевритов: монография. — Барнаул: Алтай. филиал ФГБУ РОНЦ им. Н. Н. Блохина РАМН, 2012. - 258 с.
3. Дужий И. Д. Клиническая плеврология. — Киев: Здоровчя, 2000
4. Переводчикова Н. И., Алексеева Т. Р. Опухолевые плевриты: диагностика и выбор терапевтической тактики // Международ. мед. журн. — 2003. — № 4. — С. 88 — 93.
5. Bejarano P. A., Nikiforov Y. E., Swenson E. S. et al. Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms // Appl. Immunohistochem Mol. Morphol. — 2000. — № 8 (3). — Р. 189— 194.
6. Cherchi P. L., Marras V., Capobianco G. et al. Immuno- histochemical evaluation of a new epithelial antigen, Ber-EP4, in ovarian cancer: preliminary results // Eur. J. Gynaecol. Oncol. — 2001. — № 22 (6). — Р. 433 — 435.
7. Dennis J. L., Hvidsten T. R., Wit E. C. et al. Cancer Res. — 2005. — № 11. — Р. 3766 — 3772.
8. Kaufmann O., Deidesheimer T., Muehlenberg M. et al. Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites // Histopathology. — 1996. — № 29 (3). — Р. 233 — 240.
9. Kubba L. A., McCluggage W. G., Liu J. et al. Thyroid transcription factor-1 expression in ovarian epithelial neoplasms // Mod. Pathol. — 2008. — № 21 (4). — Р. 485 — 490.
10. Kummar S., Fogarasi M., Canova A. et al. Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma // Br. J. Cancer. — 2002. — № 86 (12). — Р. 1884— 1887.
11. Lee B. H., Hecht J. L., Pinkus J. L. et al. WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids // Am. J. Clin. Pathol. — 2002. — № 117 (5). — Р. 745 — 750.
12. McCluggage W. G., Sumathi V. P., McBride H. A. et al. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas // Int. J. Gynecol. Pathol. — 2002. — № 21 (1). — Р. 11 — 15.
13. Okamoto S., Ito K., Sasano H. et al. Ber-EP4 and anticalretinin antibodies: a useful combination for differential diagnosis of various histological types of ovarian cancer cells and mesothelial cells // Tohoku J. Exp. Med. — 2005. — № 206. — Р. 31—40.
14. Ordonez N. G. Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M. D. Anderson experience and a critical review of the literature // Am. J. Clin. Pathol. — 1998. — № 109 (1). — Р. 85 — 89.
15. Ordonez N. G. Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas // Adv. Pathol. — 2000. — № 7.— Р. 123—127.
16. PaiR. K., West R. B. MOC-31 exhibits superior reactivity compared with Ber-EP4 in invasive lobular and ductal carcinoma of the breast: a tissue microarray study //Appl. Immunohistochem. Mol. Morphol. — 2009. — № 17 (3). — Р. 202 — 206.
17. Rekhtman N., AngD. C., Sima C. S. Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens // Modern Pathology. — 2011. — № 24. — Р. 1348—1359.
18. Sasaki E., Tsunoda N., Hatanaka Y. et al. Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers // Mod. Pathol. — 2007. — № 20 (2). — Р. 208 — 214.
19. Smith S. R., Howell A., Minawa A., Morrison J. M. The clinical value of immunohistochemically demonstrable CEA in breast cancer: a possible method of selecting patients for adjuvant chemotherapy // Br. J. Cancer. — 1982. — № 46 (5). — Р. 757 — 764.
20. Stenhouse G., Fyfe N., King G. et al. Thyroid transcription factor 1 in pulmonary adenocarcinoma // J. Clin. Pathol. — 2004. — № 57. — Р. 383 — 387.
21. Vang R., Gown A. M., Barry T. S. et al. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases // Am. J. Surg. Pathol. — 2006. - № 30 (9). - Р. 1130-1139.
Review
For citations:
Ivanov O.V., Klimenko V.N., Novik V.I., Nikolaev G.V. Immunohistochemistry is the method of choice in the differential diagnosis of neoplastic pleurisies of unknown etiology. The Scientific Notes of the Pavlov University. 2016;23(2):42-46. (In Russ.)